- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01772537
The Effects of Anesthesia on Patients Undergoing Surgery for Repair of a Thoracoabdominal Aneurysm.
March 2, 2017 updated by: Johns Hopkins University
The Effect of Anesthesia on Potential Cerebrospinal Fluid (CSF) and Serum Markers of Alzheimer's Disease.
Alzheimer's disease represents a growing public health problem in developed countries.
Although the pathogenesis is not clearly defined, accumulation of extracellular amyloid, neurofibrillary tangles and neuronal loss are the hallmarks of Alzheimer's disease.
The effect of anesthetic agents on changes in these proteins in humans is not well characterized, but in-vitro evidence suggests that anesthetic agents can accelerate potential pathogenic mechanisms, such as increasing amyloid formation or rates of apoptosis in cultured cells and increasing amyloid levels in mice.
Human data on the effect of anesthetic agents on amyloid and tau proteins is limited to a small series of 11 patients and showed a significant increase in tau levels after exposure to anesthetics.
In this study the investigators propose to measure CSF and serum biomarkers in a population of patients with normal CSF dynamics, who are undergoing surgery for repair of a thoracoabdominal aneurysm.
The investigators will also obtain preliminary data on whether changes in CSF levels of these proteins are associated with postoperative delirium or cognitive change.
Study Overview
Status
Terminated
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
14
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Maryland
-
Baltimore, Maryland, United States, 21287
- Johns Hopkins Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
21 years to 100 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- age 21-100 years of age
- Patients presenting for surgical repair of a thoracoabdominal aneurysm
- Insertion of a CSF spinal drain for clinically indicated reason
Exclusion Criteria:
- Patients with pre-existing delirium
- Inability to speak and understand English
- Severe hearing impairment, resulting in inability to converse
- Pregnancy. Pregnancy status will be assessed using a serum pregnancy test during preoperative evaluation as part of the standard of care.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
No Intervention: Open repair of thoracoabdominal aneurysms
These will be patients undergoing an open repair of thoracoabdominal aneurysms with or without cardiopulmonary bypass.
The will be observational only.
|
|
Active Comparator: Stent graft repair of thoracoabdominal aneurysms isoflurane
These patients are patients receiving repair of thoracoabdominal aneurysms using stent grafts.
These patients will be randomized to receive isoflurane as their primary anesthetic.
|
|
Active Comparator: Stent graft repair of thoracoabdominal aneurysms propofol
These patients are patients receiving repair of thoracoabdominal aneurysms using stent grafts.
These patients will be randomized to receive propofol as their primary anesthetic.
|
Intravenous anesthetic
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Changes in Cerebrospinal Fluid (CSF) Levels of Tau
Time Frame: From insertion of spinal drain until removal
|
Quantitative levels of tau will be measured using ELISA assay technique in pg/ml to compare the differences between the group receiving Propofol and the groups receiving Isoflurane. . |
From insertion of spinal drain until removal
|
Changes in CSF Levels of Amyloid
Time Frame: From insertion of spinal drain until removal
|
Quantitative levels of amyloid will be measured using ELISA assay technique in pg/ml to compare the differences between the group receiving Propofol and the groups receiving Isoflurane.
|
From insertion of spinal drain until removal
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Number of Participants With Delirium as Assessed by the Confusion Assessment Method (CAM)
Time Frame: Immediately after surgery and at 3 and 12 months post-op
|
Delirium was measured using the Confusion Assessment Method and the Confusion Assessment Method- Intensive Care Unit (CAM-ICU) based upon post-operative location of patient.
The patients were divided into to two groups, patients that had an open thoracoabdominal aneurysm repair versus patients that had stenting of their aneurysms.
Patients that had stenting of their aneurysms were also randomized to receive either Propofol or Isoflurane as for their anesthetic.
|
Immediately after surgery and at 3 and 12 months post-op
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Serum Inflammatory Markers
Time Frame: From the start of the surgery to 24 hours post-op
|
Serum inflammatory markers will be compared per anesthetic group, Propofol versus Isoflurane.
A sample of 10 individuals from each group will have biomarkers measured
|
From the start of the surgery to 24 hours post-op
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
May 1, 2012
Primary Completion (Actual)
February 1, 2014
Study Completion (Actual)
February 1, 2014
Study Registration Dates
First Submitted
January 17, 2013
First Submitted That Met QC Criteria
January 17, 2013
First Posted (Estimate)
January 21, 2013
Study Record Updates
Last Update Posted (Actual)
March 31, 2017
Last Update Submitted That Met QC Criteria
March 2, 2017
Last Verified
March 1, 2017
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Cardiovascular Diseases
- Vascular Diseases
- Aortic Diseases
- Aortic Aneurysm
- Aneurysm
- Aortic Aneurysm, Abdominal
- Aortic Aneurysm, Thoracic
- Physiological Effects of Drugs
- Central Nervous System Depressants
- Anesthetics, Intravenous
- Anesthetics, General
- Anesthetics
- Hypnotics and Sedatives
- Anesthetics, Inhalation
- Propofol
- Isoflurane
Other Study ID Numbers
- NA_00067716
- 5KL2RR025006 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cardiopulmonary Bypass
-
Baxter Healthcare CorporationCompletedCardiopulmonary Bypass | Sternotomy | Cardiac Surgery Requiring Cardiopulmonary Bypass and Median SternotomyUnited States
-
Nanjing First Hospital, Nanjing Medical UniversityCompletedCardiopulmonary Bypass | Coronary Artery Bypass GraftingChina
-
University Hospital, GhentCompletedCardiopulmonary Bypass
-
Aristotle University Of ThessalonikiCompletedHeparin and Protamine Titration in Cardiac Surgery Under Minimal Invasive Extracorporeal CirculationCardiopulmonary BypassGreece
-
University Medical Centre LjubljanaSlovenian Research AgencyCompleted
-
Ulf BorgMedtronic - MITGCompletedCardiopulmonary BypassChina
-
Emory UniversityChildren's Research Oversight Committee FundsCompletedCardiopulmonary BypassUnited States
-
University of Texas Southwestern Medical CenterChildren's Medical Center DallasUnknownCardiopulmonary BypassUnited States
-
Loma Linda UniversityCompletedCardiopulmonary BypassUnited States
-
Umeå UniversityCompletedCardiopulmonary BypassSweden
Clinical Trials on isoflurane
-
Konkuk University Medical CenterCompletedIschemic Heart Disease | Valvular Heart DiseaseKorea, Republic of
-
UPECLIN HC FM Botucatu UnespFundação de Amparo à Pesquisa do Estado de São PauloCompletedPatients in Good HealthBrazil
-
University of ChicagoNational Institute on Drug Abuse (NIDA)CompletedSubstance-Related Disorders | Opioid-Related DisordersUnited States
-
UMC UtrechtTerminated
-
University of ChicagoNational Institute on Drug Abuse (NIDA)CompletedSubstance-Related Disorders | Opioid-Related DisordersUnited States
-
Sichuan UniversityCompleted
-
Azienda Ospedaliera Città della Salute e della...CompletedSubarachnoid Hemorrhage | Aneurysmal Subarachnoid HemorrhageItaly
-
University of EdinburghCompletedCardiopulmonary Bypass | Consciousness Monitors | IsofluraneUnited Kingdom
-
University of MichiganUniversity of Pennsylvania; Washington University School of Medicine; James S...Completed
-
Aga Khan UniversityCompleted